Skip to main content
NVDA-0.15%AAPL+0.06%GOOGL-1.17%MSFT-0.06%AMZN-0.01%TSM+2.85%SPCX-1.20%AVGO+0.21%META-0.30%TSLA-0.32%SKHY+8.14%MU-0.23%BRK-B-0.41%LLY-0.98%JPM-0.94%WMT-1.18%AMD+4.69%V-0.97%JNJ-1.15%XOM-1.70%ASMLa+3.40%0700.HK+2.26%MA-1.11%INTC+4.51%1398.HK+1.99%ORCL+3.11%ABBV-1.49%BAC-0.57%CSCO+0.54%CVX-1.32%COST-1.04%LRCX+5.12%KO-0.83%CAT+1.72%0005.HK+1.96%HSBA.L+1.06%AMAT+4.31%UNH-0.95%AP2d+4.21%GE+1.09%PG-0.33%DELL+1.47%MS+0.25%3988.HK+2.02%1816.HK-0.68%NFLX-5.35%HD+0.94%0857.HK+1.40%GS+0.07%NVS-1.90%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPZAR0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%AUDCAD0.00%GBPCAD0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%EURHKD0.00%EURCHF0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURSGD0.00%EURZAR0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%AUDDKK0.00%CHFSGD0.00%AUDJPY0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDPLN0.00%NZDJPY0.00%EURDKK0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GAGUSD0.00%C10.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-1.95%BTCUSDT+4.89%ETHUSD-2.19%USDTUSD0.00%BNBUSDT+14.24%XRPUSD-3.91%SOLUSD-2.15%TRXUSDT+0.28%ZECUSDT+7.34%DOGEUSD-3.71%XMRUSDT-0.55%ADAUSDT-15.61%LINKUSD-1.77%XLMUSD-2.96%XLMUSDT+2.96%BCHUSDT-2.03%AVAXUSDT-21.55%LTCUSD-1.37%UNIUSD-3.33%SUIUSDT-20.62%TONUSD+25.16%HBARUSDT-2.02%TONUSDT+27.64%SUIUSD-3.87%TAOUSDT-1.40%UNIUSDT+88.28%AAVEUSD-2.32%NEARUSDT+55.38%PEPEUSD+10008521.15%DOTUSDT-1.80%ICPUSDT-2.32%ETCUSDT-12.43%ONDOUSDT-2.26%WLDUSDT-3.78%ARBUSDT-8.04%ATOMUSDT-1.22%JUPUSDT-5.62%PENGUUSDT+95570.62%STXUSDT-4.51%INJUSDT-4.57%FETUSDT-2.40%PYTHUSDT-1.90%SEIUSDT-5.66%TIAUSDT-4.94%IMXUSDT-1.66%WIFUSDT-6.06%OPUSDT-3.65%GRTUSDT-2.91%NVDA-0.15%AAPL+0.06%GOOGL-1.17%MSFT-0.06%AMZN-0.01%TSM+2.85%SPCX-1.20%AVGO+0.21%META-0.30%TSLA-0.32%SKHY+8.14%MU-0.23%BRK-B-0.41%LLY-0.98%JPM-0.94%WMT-1.18%AMD+4.69%V-0.97%JNJ-1.15%XOM-1.70%ASMLa+3.40%0700.HK+2.26%MA-1.11%INTC+4.51%1398.HK+1.99%ORCL+3.11%ABBV-1.49%BAC-0.57%CSCO+0.54%CVX-1.32%COST-1.04%LRCX+5.12%KO-0.83%CAT+1.72%0005.HK+1.96%HSBA.L+1.06%AMAT+4.31%UNH-0.95%AP2d+4.21%GE+1.09%PG-0.33%DELL+1.47%MS+0.25%3988.HK+2.02%1816.HK-0.68%NFLX-5.35%HD+0.94%0857.HK+1.40%GS+0.07%NVS-1.90%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPZAR0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%AUDCAD0.00%GBPCAD0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%EURHKD0.00%EURCHF0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURSGD0.00%EURZAR0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%AUDDKK0.00%CHFSGD0.00%AUDJPY0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDPLN0.00%NZDJPY0.00%EURDKK0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GAGUSD0.00%C10.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-1.95%BTCUSDT+4.89%ETHUSD-2.19%USDTUSD0.00%BNBUSDT+14.24%XRPUSD-3.91%SOLUSD-2.15%TRXUSDT+0.28%ZECUSDT+7.34%DOGEUSD-3.71%XMRUSDT-0.55%ADAUSDT-15.61%LINKUSD-1.77%XLMUSD-2.96%XLMUSDT+2.96%BCHUSDT-2.03%AVAXUSDT-21.55%LTCUSD-1.37%UNIUSD-3.33%SUIUSDT-20.62%TONUSD+25.16%HBARUSDT-2.02%TONUSDT+27.64%SUIUSD-3.87%TAOUSDT-1.40%UNIUSDT+88.28%AAVEUSD-2.32%NEARUSDT+55.38%PEPEUSD+10008521.15%DOTUSDT-1.80%ICPUSDT-2.32%ETCUSDT-12.43%ONDOUSDT-2.26%WLDUSDT-3.78%ARBUSDT-8.04%ATOMUSDT-1.22%JUPUSDT-5.62%PENGUUSDT+95570.62%STXUSDT-4.51%INJUSDT-4.57%FETUSDT-2.40%PYTHUSDT-1.90%SEIUSDT-5.66%TIAUSDT-4.94%IMXUSDT-1.66%WIFUSDT-6.06%OPUSDT-3.65%GRTUSDT-2.91%
VE

Vericel Corporation (VCEL)

NASDAQHealthcare

$40.19
-$0.28 (-0.7%)
Market closed

Last close at September 4, 2026 at 20:00 UTC

Day Range$39.85 - $40.52
Avg. Volume (3M)469K
Market Cap$2B
P/E Ratio83.7
52 Week Range
$28.95$49.32
Next EarningsIn 62 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$77.4M100%
Gross Profitminus cost of goods$56.4M73%
Operating Incomeminus R&D and overhead$434K1%
Net Incomeminus taxes and the rest$2.2M3%

In plain terms: out of every $100 in revenue, Vericel Corporation keeps $3 as net profit.

Fundamentals & Financials

Revenue (TTM)
$306.3M
Net Income (TTM)
$24.2M
EPS (TTM)
$0.48
ROA (TTM)
4.82%
Current Ratio
5.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026$0.45
+20.0%Q2 2026-$0.12
+238.2%Q3 2026$0.04
Next

Nov 5

in 62 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +238.2%

Vericel’s revenue topped consensus and rose year over year in the second fiscal quarter of 2026, reported July 30, 2026, with revenue of $77.5 million against a $72.7 million estimate, +6.5%, and up 22.5% from roughly $63.2 million a year ago. Profitability remained concentrated in gross profit, which came in at about $56.4 million with gross margin near 73%, while operating income was roughly $0.4 million for an operating margin of about 0.6%. Net income was about $2.2 million, improving from roughly negative $0.6 million a year ago, and EPS was $0.04 versus $-0.01 in the prior-year period. The company generated operating cash flow of about $16.2 million. For the next period, consensus calls for EPS of $0.02 on revenue of $78.0 million.

View full earnings history

About Vericel Corporation

Vericel Corporation is a NASDAQ-listed healthcare company focused on biotechnology-based cell therapies. It researches, develops, produces, and distributes treatments for sports medicine and critical burn care in the United States, where it generated $276.3 million of revenue in FY2025 from its marketed burn-care and cartilage-repair portfolio.

Name
Vericel Corporation
CEO
Dominick C. Colangelo
Website
Industry
Healthcare
Year Founded
1989
Employees
398

Today's Snapshot

AI-generated

VCEL closed 0.7% below yesterday's close, in line with a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.

Trading Volume

Below 10d avg (491.4K)

312.9K

vs S&P 500 Today

Moderate Underperformance

-0.27%

Updated: September 4, 2026 at 20:21 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
VCEL leans toward a sell as momentum and medium-term moving averages press the price lower despite the 200-day averages sitting below current levels. Momentum measures are weak with RSI in the mid-30s, a negative MACD and a deeply negative CCI, while the broader trend lacks conviction with ADX under 20. Volatility is moderate with an ATR near 1.4, and on-balance volume signals distribution. The price is close to the classic pivot, but short- and intermediate-term averages remain resistive. Technical takeaway: Sell — momentum and moving-average alignment favor downside pressure.
All signals
  • EMA (5 indicators)$39.12 - $42.62
    Sell
  • RSI (14)35.63
    Neutral
  • Stochastic %K (14, 3, 3)17.64
    Buy
  • MACD Level (12, 26)-1.15
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.